Using Biological Markers to Predict Risk of Radiation Injury

Seminars in Radiation Oncology

Volumn 17, Issue 2, 2007, Pages 89-98

  Fleckenstein, Katharina ^a,b   Gauter Fleckenstein, Benjamin ^a,b   Jackson, Isabel L ^a   Rabbani, Zahid ^a   Anscher, Mitchell ^c   Vujaskovic, Zeljko ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; EDEMA; EVALUATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HYPOXIA; ISCHEMIA; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG INJURY; MACROPHAGE; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RESPIRATORY BURST; RISK ASSESSMENT; RISK FACTOR; THORAX;

BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INTERLEUKINS; LUNG; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33947513051     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.11.004     Document Type: Article

References (61)

1. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63 (2005) 5-24
2. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
3. Willner J., Baier K., Caragiani E., et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
4. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-A systematic review. Radiother Oncol 71 (2004) 127-138
5. Castellino R.A., Glatstein E., Turbow M.M., et al. Latent radiation injury of lungs or heart activated by steroid withdrawal. Ann Intern Med 80 (1974) 593-599
6. Morgan G.W., and Breit S.N. Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31 (1995) 361-369
7. Rubin P., Shapiro D.L., Finklestein J.N., et al. The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys 6 (1980) 75-77
8. Vujaskovic Z., Anscher M.S., Feng Q.F., et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50 (2001) 851-855
9. Herskind C., Bamberg M., and Rodemann H.P. The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol 174 suppl 3 (1998) 12-15
10. Rube C.E., Uthe D., Wilfert F., et al. The bronchiolar epithelium as a prominent source of pro-inflammatory cytokines after lung irradiation. Int J Radiat Oncol Biol Phys 61 (2005) 1482-1492
11. Rubin P., Johnston C.J., Williams J.P., et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 (1995) 99-109
12. Vujaskovic Z., Marks L.B., and Anscher M.S. The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin Radiat Oncol 10 (2000) 296-307
13. Johnston C.J., Williams J.P., Elder A., et al. Inflammatory cell recruitment following thoracic irradiation. Exp Lung Res 30 (2004) 369-382
14. Rubin P., Finkelstein J., and Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: Interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys 24 (1992) 93-101
15. Sun Y., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic Biol Med 21 (1996) 335-348
16. Wu X., Bishopric N.H., Discher D.J., et al. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16 (1996) 1035-1046
17. Schmidt-Ullrich R.K., Dent P., Grant S., et al. Signal transduction and cellular radiation responses. Radiat Res 153 (2000) 245-257
18. Martin M., Lefaix J., and Delanian S. TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys 47 (2000) 277-290
19. Rube C.E., Uthe D., Schmid K.W., et al. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 47 (2000) 1033-1042
20. Yi E.S., Bedoya A., Lee H., et al. Radiation-induced lung injury in vivo: Expression of transforming growth factor-beta precedes fibrosis. Inflammation 20 (1996) 339-352
21. Hakenjos L., Bamberg M., and Rodemann H.P. TGF-beta1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 76 (2000) 503-509
22. Haroon Z.A., Amin K., Jiang X., et al. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163 (2003) 993-1000
23. Moeller B.J., Cao Y., Vujaskovic Z., et al. The relationship between hypoxia and angiogenesis. Semin Radiat Oncol 14 (2004) 215-221
24. Shweiki D., Itin A., Soffer D., et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
25. Anscher M.S., Kong F.M., Andrews K., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41 (1998) 1029-1035
26. Anscher M.S., Kong F.M., Marks L.B., et al. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 37 (1997) 253-258
27. Anscher M.S., Murase T., Prescott D.M., et al. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 30 (1994) 671-676
28. Anscher M.S., Marks L.B., Shafman T.D., et al. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19 (2001) 3758-3765
29. Anscher M.S., Marks L.B., Shafman T.D., et al. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 988-995
30. Fu X.L., Huang H., Bentel G., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50 (2001) 899-908
31. Kong F.M., Anscher M.S., Sporn T.A., et al. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys 49 (2001) 35-41
32. Dennis P.A., and Rifkin D.B. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A 88 (1991) 580-584
33. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61 (1992) 307-330
34. De Jaeger K., Seppenwoolde Y., Kampinga H.H., et al. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1378-1387
35. Jeremic B., Hennig M., and Zimmermann F.B. Predictors of radiation pneumonitis after radiotherapy in lung cancer. Int J Radiat Oncol Biol Phys 61 (2005) 302
36. Vujaskovic Z., and Groen H.J. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol 76 (2000) 511-516
37. Novakova-Jiresova A., Van Gameren M.M., Coppes R.P., et al. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 71 (2004) 183-189
38. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39 (1997) 563-570
39. Chen Y., Williams J., Ding I., et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12 (2002) 26-33
40. Barthelemy-Brichant N., Bosquee L., Cataldo D., et al. Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 758-767
41. Anscher M.S., Peters W.P., Reisenbichler H., et al. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328 (1993) 1592-1598
42. Murase T., Jirtle R.L., and McDonald G.B. Transforming growth factor-beta plasma concentrations in patients with leukemia and lymphoma receiving chemoradiotherapy and marrow transplantation. Blood 83 (1994) 2383
43. van Waarde M.A., van Assen A.J., Kampinga H.H., et al. Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 247 (1997) 45-51
44. National Cancer Institute Common Toxicity Criteria, Bethesda version 2.0 (2003)
45. LENT SOMA tables. Radiother Oncol 35 (1995) 17-60
46. Arpin D., Perol D., Blay J.Y., et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23 (2005) 8748-8756
47. Chen Y., Rubin P., Williams J., et al. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49 (2001) 641-648
48. Chen Y., Hyrien O., Williams J., et al. Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62 (2005) 260-266
49. Hart J.P., Broadwater G., Rabbani Z., et al. Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys 63 (2005) 1448-1454
50. Kohno N., Kyoizumi S., Awaya Y., et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96 (1989) 68-73
51. Kohno N., Hamada H., Fujioka S., et al. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102 (1992) 117-122
52. Goto K., Kodama T., Sekine I., et al. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis. Lung Cancer 34 (2001) 141-148
53. Matsuno Y., Satoh H., Ishikawa H., et al. Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy. Med Oncol 23 (2006) 75-82
54. Hara R., Itami J., Komiyama T., et al. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors. Chest 125 (2004) 340-344
55. Kobayashi J., and Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 108 (1995) 311-315
56. Sasaki R., Soejima T., Matsumoto A., et al. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis. Int J Radiat Oncol Biol Phys 50 (2001) 301-307
57. Takahashi H., Imai Y., Fujishima T., et al. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis. Eur Respir J 17 (2001) 481-487
58. Susskind H., Hymowitz M.H., Lau Y.H., et al. Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1161-1169
59. Ishii Y., and Kitamura S. Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis. Eur Respir J 13 (1999) 733-738
60. Hoeller U., Tribius S., Kuhlmey A., et al. Increasing the rate of late toxicity by changing the score?. A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 55 (2003) 1013-1018
61. Maasilta P., Salonen E.M., Vaheri A., et al. Procollagen-III in serum, plasminogen activation and fibronectin in bronchoalveolar lavage fluid during and following irradiation of human lung. Int J Radiat Oncol Biol Phys 20 (1991) 973-980